Protek Finance LLC became a new shareholder of its parent company OAO Protek buying 0.8522% of its shares, while CJSC CV Protek increased its stake in OAO Protek to 1.7118% from 0.4620%).
Protek Group (tax number: 7715354473) is a Russian pharmaceuticals distributor. The group's key companies in various segments are: national distributor of pharmaceuticals and healthcare & beauty products CJSC CV Protek, network of pharmacies Rigla and pharmaceutical manufacturer FarmFirma Sotex.
IFRS net profit of Protek Group for 2013 decreased by 31% to RUB 1.932 billion against RUB 2.81 billion the year before. Revenue increased by 11% to RUB 139.31 billion from RUB 125.502 billion, GP by 13% to RUB 17.544 billion from RUB 15.469 billion. Operating profit decreased by 35% to RUB 2.271 billion from RUB 3.478 billion, pre-tax profit by 29% to RUB 2.537 billion from RUB 3.586 billion.
According to the DataCapital information retrieval system, RAS net profit of OAO Protek for 2013 grew 3.27-fold to RUB 3.299 billion from RUB 1.008 billion the year before. Revenue increased by 11.4% to RUB 136.471 million from RUB 122.527 million, GP by 6% to RUB 11.018 million from RUB 10.382 million, pre-tax profit 3 times to RUB 3.332 billion from RUB 1.039 billion.
Protek Group's revenue for Q1 2014 increased by 6.2% to RUB 36.826 billion from RUB 34.677 billion the year before.